Email updates

Keep up to date with the latest news and content from BMC Medicine and BioMed Central.

Journal App

google play app store
Open Access Commentary

Crosstalk between HIV and hepatitis C virus during co-infection

Paul J Rider1 and Fenyong Liu12*

Author Affiliations

1 School of Public Health, University of California, Berkeley, CA 94720, USA

2 Program in Comparative Biochemistry, University of California, Berkeley, CA 94720, USA

For all author emails, please log on.

BMC Medicine 2012, 10:32  doi:10.1186/1741-7015-10-32

Published: 3 April 2012

Abstract

An estimated one-third of individuals positive for HIV are also infected with hepatitis C virus (HCV). Chronic infection with HCV can lead to serious liver disease including cirrhosis and hepatocellular carcinoma. Liver-related disease is among the leading causes of death in patients with HIV, and individuals with HIV and HCV co-infection are found to progress more rapidly to serious liver disease than mono-infected individuals. The mechanism by which HIV affects HCV infection in the absence of immunosuppression by HIV is currently unknown. In a recent article published in BMC Immunology, Qu et al. demonstrated that HIV tat is capable of inducing IP-10 expression. Further, they were able to show that HIV tat, when added to cells, was able to enhance the replication of HCV. Importantly, the increase in HCV replication by tat was found to be dependent on IP-10. This work has important implications for understanding the effect HIV has on the outcome of HCV infection in co-infected individuals. The findings of Qu et al. may inform the design of intervention and treatment strategies for co-infected individuals.

Please see related article: http://www.biomedcentral.com/1471-2172/13/15 webcite.

Keywords:
Co-infection; HIV; HCV; IP-10